• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

Professional Introduction to (2S,4S)-Tert-Butyl 4-amino-2-(methoxymethyl)pyrrolidine-1-carboxylate (CAS No. 1123305-98-5)

(2S,4S)-Tert-Butyl 4-amino-2-(methoxymethyl)pyrrolidine-1-carboxylate is a highly specialized chiral compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by its CAS number 1123305-98-5, is a derivative of pyrrolidine and features a unique stereochemical configuration that makes it a valuable building block for the synthesis of complex molecules. The presence of both amino and methoxymethyl functional groups, along with the tert-butyl substituent, contributes to its versatility in chemical transformations and biological activities.

The stereochemistry of this compound, specifically the (2S,4S) configuration, is critical for its intended applications. Chiral compounds like this one are often used in the development of enantiomerically pure drugs, where the spatial arrangement of atoms can significantly influence the biological activity and efficacy of a therapeutic agent. The precise stereochemical control required for synthesizing such compounds underscores the importance of advanced synthetic methodologies and analytical techniques.

In recent years, there has been a growing interest in the use of pyrrolidine derivatives in medicinal chemistry due to their broad range of biological activities. For instance, studies have demonstrated that pyrrolidine-based scaffolds can exhibit properties relevant to neurodegenerative diseases, cardiovascular disorders, and anti-inflammatory responses. The compound (2S,4S)-Tert-butyl 4-amino-2-(methoxymethyl)pyrrolidine-1-carboxylate is being explored as a potential precursor in the synthesis of novel therapeutic agents that target these conditions.

One of the most compelling aspects of this compound is its utility in fragment-based drug design. Fragment-based approaches involve identifying small molecular fragments that exhibit promising biological activity and then using them as building blocks to develop more complex and potent drugs. The structural features of (2S,4S)-Tert-butyl 4-amino-2-(methoxymethyl)pyrrolidine-1-carboxylate, including its amino and methoxymethyl groups, make it an ideal candidate for such strategies. These functional groups can be readily modified through various chemical reactions to introduce additional pharmacophores or enhance specific biological interactions.

The synthesis of this compound involves multiple steps, each requiring careful optimization to ensure high yield and purity. Advanced techniques such as asymmetric catalysis and chiral auxiliary-assisted methods are often employed to achieve the desired stereochemical configuration. The use of transition metal catalysts, for example, can facilitate highly selective reactions that are crucial for constructing complex chiral molecules like this one.

Recent advancements in computational chemistry have also played a significant role in the study of this compound. Molecular modeling techniques allow researchers to predict the biological activity and interactions of (2S,4S)-Tert-butyl 4-amino-2-(methoxymethyl)pyrrolidine-1-carboxylate with target proteins or receptors before conducting expensive experimental trials. This approach not only accelerates the drug discovery process but also helps in identifying potential lead compounds with high binding affinity and selectivity.

The pharmacological potential of this compound has been further explored through in vitro and in vivo studies. Initial research suggests that derivatives of pyrrolidine can modulate various signaling pathways involved in disease progression. For example, modifications to the amino group might enable interactions with specific enzymes or receptors, while the methoxymethyl moiety could serve as a linker for additional functional groups. These findings highlight the importance of structure-activity relationship (SAR) studies in optimizing the therapeutic properties of such compounds.

The role of stereochemistry in determining biological activity cannot be overstated. Enantiomers, which are mirror-image isomers of chiral compounds, can exhibit vastly different pharmacological effects. This phenomenon underscores why precise control over stereochemistry is essential in drug development. The synthesis and characterization of racemic mixtures or diastereomers can lead to unintended side effects or reduced efficacy, making stereochemical purity a critical factor in pharmaceutical research.

In conclusion, (2S,4S)-Tert-butyl 4-amino-2-(methoxymethyl)pyrrolidine-1-carboxylate (CAS No. 1123305-98-5) represents a significant advancement in chiral chemistry and pharmaceutical research. Its unique structural features and stereochemical configuration make it a valuable tool for developing novel therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound and related derivatives, its importance in medicinal chemistry is likely to grow even further.

• 833473-66-8(1-Pyrrolidinecarboxylic acid, 2-(hydroxymethyl)-3-(4-morpholinyl)-, 1,1-dimethylethyl ester, (2S,3S)-)
• 1217657-92-5(2-methyl-2-propanyl (2s,4r)-4-amino-2-(hydroxymethyl)-1-pyrrolidi Necarboxylate Hydrochloride (1:1))
• 1279037-19-2((2S,4S)-1-Boc-2-(Hydroxymethyl)-4-(methylamino)pyrrolidine)
• 1279038-32-2((2S,4R)-1-Boc-2-Hydroxymethyl-4-aminopyrrolidine hydrochloride)
• 1217803-39-8((2S,4S)-tert-Butyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate hydrochloride)
• 1116454-27-3(tert-butyl (2S,4R)-4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate)
• 1161931-71-0(tert-butyl (2R,4R)-4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate)
• 179472-26-5(tert-butyl (2R,4S)-4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate)
• 922139-40-0(tert-butyl (2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate)
• 1207853-53-9(tert-butyl (2S,4R)-4-amino-2-(methoxymethyl)pyrrolidine-1-carboxylate)